Dose Group (n) | ABC-Corea | ABC-Totala | CGI-I Question 1bc | CGI-I 24 itembc | ATECac |
---|---|---|---|---|---|
10Â mg/kg (13) | |||||
Mean change from BL ± SE | − 12.3 ± 3.25 | − 32.0 ± 6.88 | 2.8 ± 0.30 | 73.4 ± 5.57 | − 20.9 ± 4.09 |
Difference from placebo: | |||||
Mean change from BL (95% CI) | − 3.9 (− 13.9, 6.1) | − 14.7 (− 35.8, 6.3) | 1.1 (0.2, 2.0) | 21.2 (4.2, 38.3) | − 4.3 (− 17.5, 9.0) |
P value, unadjusted | 0.37 | 0.12 | 0.008 | 0.007 | 0.46 |
P-value, adjustedd | 0.58 | 0.20 | 0.016 | 0.013 | 0.68 |
20Â mg/kg (14) | |||||
Mean change from BL ± SE | − 6.5 ± 2.89 | − 16.2 ± 6.13 | 2.0 ± 0.28 | 59.5 ± 5.11 | − 15.2 ± 4.04 |
Difference from placebo: | |||||
Mean change from BL (95% CI) | 2.0 (− 7.5, 11.4) | 1.1 (− 18.9, 21.0) | 0.3 (− 0.6, 1.2) | 7.3 (− 9.1, 23.7) | 1.5 (− 12.0, 14.9) |
P value, unadjusted | 0.64 | 0.90 | 0.43 | 0.31 | 0.80 |
P-value, adjustedd | 0.85 | 0.99 | 0.65 | 0.50 | 0.96 |
Placebo (14) | |||||
Mean change from BL ± SE | − 8.4 ± 2.91 | − 17.3 ± 6.17 | 1.7 ± 0.27 | 52.2 ± 4.99 | − 16.6 ± 4.07 |